Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Stroke|February 27, 2007
Blood pressure and estimated risk of stroke in the elderly population of Spain: the PREV-ICTUS studyJosep Redón, Luis Cea-Calvo, José V Lozano, et al.Journal of Hypertension|December 5, 2006
First-year blood pressure increase steepest in low birthweight newbornsEmpar Lurbe, Consuelo Garcia-Vicent, Isabel Torro, et al.Blood Pressure|September 25, 2013
Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind studyJosep Redón, Jose M Pascual-Izuel, Enrique Rodilla, et al.Blood Pressure|November 3, 2006
Estimated risk of a first stroke and conditioning factors in Spanish hypertensive women. The RIMH studyAntonio Coca, Josep Redón, Luis Cea-Calvo, et al.Revista Espanola De Cardiologia|March 15, 2011
[In the identification of cardiovascular risk with the SCORE model, could we recommend its calculation interchangeably with total cholesterol or atherogenic index? Concordance between total cholesterol and atherogenic index in the SCORE table]Vicente F Gil-Guillén, Domingo Orozco-Beltrán, Salvador Pita-Fernández, et al.International Journal of Cardiology|June 24, 2019
Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, SpainJosep Redón, Ruth Usó, Jose Luis Trillo, et al.Revista Espanola De Cardiologia|August 27, 2010
Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trialPedro Morillas, Vicente Pallarés, José Luis Llisterri, et al.Journal of Hypertension|July 11, 2007
A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertensionMaría U Moreno, Gorka San José, Ana Fortuño, et al.Diabetes Research and Clinical Practice|December 24, 2023
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based studyAna Palanca, F Javier Ampudia-Blasco, José Miguel Calderón, et al.Biomolecules|July 29, 2025
Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal DamageOlga Martinez-Arroyo, Ana Flores-Chova, Marta Mendez-Debaets, et al.Pageof 8